Johnson Matthey signs supply agreement with US biopharmaceutical firm

MOSCOW (MRC) -- Johnson Matthey (JM; London, UK) says it has entered into a five-year supply agreement with Sarepta Therapeutics (Andover, Massachusetts), a biopharmaceutical company, said Chemweek.According to the terms of the agreement, JM will continue to provide regulatory starting materials to support Sarepta's programs for phosphorodiamidate morpholino oligomer (PMO) and peptide pho

Full article at mrcplast.com